112 related articles for article (PubMed ID: 8535026)
21. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells.
Ehring GR; Osipchuk YV; Cahalan MD
J Gen Physiol; 1994 Dec; 104(6):1129-61. PubMed ID: 7699367
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
23. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
24. Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells.
Kurowski C; Berthold F
Ann Oncol; 1998 Sep; 9(9):1009-14. PubMed ID: 9818076
[TBL] [Abstract][Full Text] [Related]
25. Scanning microspectrofluorometry of rhodamine 123 in multidrug-resistant cells.
Millot JM; Sharonov S; Manfait M
Cytometry; 1994 Sep; 17(1):50-8. PubMed ID: 8001458
[TBL] [Abstract][Full Text] [Related]
26. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants.
Cox DS; Scott KR; Gao H; Raje S; Eddington ND
J Pharm Sci; 2001 Oct; 90(10):1540-52. PubMed ID: 11745712
[TBL] [Abstract][Full Text] [Related]
27. Interaction of rhodamine 123 with living cells studied by flow cytometry.
Darzynkiewicz Z; Traganos F; Staiano-Coico L; Kapuscinski J; Melamed MR
Cancer Res; 1982 Mar; 42(3):799-806. PubMed ID: 7059978
[TBL] [Abstract][Full Text] [Related]
28. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds.
Versantvoort CH; Rhodes T; Twentyman PR
Br J Cancer; 1996 Dec; 74(12):1949-54. PubMed ID: 8980395
[TBL] [Abstract][Full Text] [Related]
29. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
Altenberg GA; Young G; Horton JK; Glass D; Belli JA; Reuss L
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9735-8. PubMed ID: 8105483
[TBL] [Abstract][Full Text] [Related]
30. Expression and function of P-glycoprotein in a mouse kidney cell line.
Ernest S; Bello-Reuss E
Am J Physiol; 1995 Aug; 269(2 Pt 1):C323-33. PubMed ID: 7653514
[TBL] [Abstract][Full Text] [Related]
31. Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers.
Boer R; Gekeler V; Ulrich WR; Zimmermann P; Ise W; Schödl A; Haas S
Eur J Cancer; 1996 May; 32A(5):857-61. PubMed ID: 9081366
[TBL] [Abstract][Full Text] [Related]
32. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
[TBL] [Abstract][Full Text] [Related]
33. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
[TBL] [Abstract][Full Text] [Related]
34. Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
Wigler PW; Patterson FK
Biochim Biophys Acta; 1994 Jan; 1189(1):1-6. PubMed ID: 7905747
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
[TBL] [Abstract][Full Text] [Related]
36. Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples.
Canitrot Y; Lahmy S; Buquen JJ; Canitrot D; Lautier D
Cancer Lett; 1996 Aug; 106(1):59-68. PubMed ID: 8827047
[TBL] [Abstract][Full Text] [Related]
37. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
Ernest S; Bello-Reuss E
Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
[TBL] [Abstract][Full Text] [Related]
38. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
[TBL] [Abstract][Full Text] [Related]
39. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
Brooks TA; O'Loughlin KL; Minderman H; Bundy BN; Ford LA; Vredenburg MR; Bernacki RJ; Priebe W; Baer MR
Invest New Drugs; 2007 Apr; 25(2):115-22. PubMed ID: 17072745
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]